Best AI Clinical Trial Matching Tools for Oncology Researchers (2026)
Finding the right clinical trial for an oncology patient is like looking for a needle in a haystack — except the haystack spans millions of data points across thousands of clinical sites, and every day spent matching manually is a day lost in the fight against cancer. AI-powered clinical trial matching tools now analyze genomic data, medical histories, and trial eligibility criteria in seconds, not weeks. These platforms use machine learning to identify eligible patients, predict trial feasibility, and generate real-world evidence from existing clinical data. But with platforms ranging from enterprise-grade AI engines to patient-facing matching portals, choosing the right one takes research of its own. We evaluated the top AI clinical trial matching platforms for oncology researchers based on data coverage, AI capabilities, EHR integration depth, and real-world outcomes.
Quick Answer
Best overall: Tempus — 4.7/5 rating with the largest multimodal oncology dataset and real-time clinical decision support.
Comparison Table
| Tool | Best For | Pricing | Rating |
|---|---|---|---|
| Tempus | Oncology researchers and clinical trial teams at large institutions | Custom pricing (enterprise) | 4.7 |
| Syapse | Health systems and oncology research networks | Custom pricing | 4.6 |
| TriNetX | Researchers conducting global trial feasibility, site selection, and cohort matching | Custom pricing (enterprise) | 4.6 |
| ConcertAI | Large research institutions and life science companies | Custom pricing (enterprise) | 4.5 |
| Leal Health | Patient-facing trial matching and research site discovery | Free for patients / Custom enterprise pricing | 4.4 |
How we score
Each tool is scored out of 10 across four weighted criteria, based on hands-on testing and public pricing pages.
Tempus
Overview: Tempus combines the largest multimodal oncology dataset with advanced AI to deliver real-time clinical trial matching and clinical decision support. Its platform ingests molecular, genomic, and clinical data to surface the most relevant trial options for every patient profile, integrated directly with EHR workflows. With AI-driven genomic trial matching across cancer types, it gives oncology researchers a comprehensive view of every available option without manual chart reviews.
Best For: Oncology researchers and clinical trial teams at large institutions
Pricing: Custom pricing (enterprise)
CTA: Try Tempus →
Syapse
Overview: Syapse delivers a precision oncology platform that unifies siloed clinical and molecular data across health systems, using AI to match patients to trials and generate real-world evidence. Its deep EHR integrations allow researchers to identify eligible patients at the point of care without disrupting clinical workflows. Syapse excels at breaking down data silos so research networks can collaborate effectively across institutions and share insights in real time.
Best For: Health systems and oncology research networks
Pricing: Custom pricing
CTA: Try Syapse →
TriNetX
Overview: TriNetX connects researchers to a global network of 309M+ patient lives across 13,000+ clinical sites in more than 20 countries, using AI to power trial feasibility analysis and real-time cohort identification. It is built for researchers who need to assess trial viability and identify matching patient populations at global scale. With over 4,000 peer-reviewed publications using its real-world data, TriNetX is the most published evidence-generation platform in oncology research today.
Best For: Researchers conducting global trial feasibility, site selection, and cohort matching
Pricing: Custom pricing (enterprise)
CTA: Try Trinetx →
ConcertAI
Overview: ConcertAI's enterprise platform leverages the CancerLinQ TriaLinQ network with over one million patient records to drive AI-powered trial matching and real-world data analysis. Its FDA-cleared AI tools integrate directly into clinical trial workflows, making it a trusted choice for large research institutions and life science companies. ConcertAI covers more than 200 cancer types, giving researchers exceptionally broad disease coverage from a single platform.
Best For: Large research institutions and life science companies
Pricing: Custom pricing (enterprise)
CTA: Try Concertai →
Leal Health
Overview: Leal Health operates at the intersection of patient needs and researcher goals, offering an AI-powered platform that has generated over three million treatment matches to date. Its dual-sided approach lets patients discover trials and researchers find eligible participants without pharma marketing influence or bias. Leal Health is the only platform on this list that offers free patient-facing access alongside enterprise-grade researcher tools, making it uniquely accessible.
Best For: Patient-facing trial matching and research site discovery
Pricing: Free for patients / Custom enterprise pricing
CTA: Try Leal Health →
FAQ
What makes AI clinical trial matching tools different from traditional methods? AI tools analyze genomic, molecular, and clinical data in real time to match patients against trial eligibility criteria, reducing what traditionally takes weeks to seconds with higher accuracy. They can surface trials that manual screening would miss, especially for complex biomarker-driven protocols.
How accurate are AI-powered trial matching platforms? Top platforms like Tempus and Syapse leverage large multimodal datasets and validated algorithms, consistently outperforming manual screening in both speed and match quality. Accuracy improves over time as AI models learn from more matched cases and outcomes data across growing patient populations.
Can these tools integrate with existing EHR systems? Yes. Most major platforms offer deep EHR integration for point-of-care trial matching, though implementation complexity varies by vendor and institutional IT environment. Tempus and Syapse lead in seamless integration, while ConcertAI typically requires more dedicated IT resources.
Conclusion
AI clinical trial matching tools are transforming oncology research by turning months of manual screening into minutes of automated analysis. Tempus leads with the largest multimodal oncology dataset and highest user rating, making it the top choice for large research institutions. For global-scale trial feasibility and cohort identification across 20+ countries, TriNetX is the clear standout. Every platform on this list brings unique strengths — your choice depends on whether you need enterprise-grade AI, global data access, or patient-facing matching capabilities.
Try Tempus → — the best AI clinical trial matching platform for oncology researchers.
Related Articles
This page contains affiliate links. We may earn a commission if you purchase through our links.